EBOS Group (ASX:EBO) Insider Buys A$36,054.00 in Stock

EBOS Group Limited (ASX:EBO) insider Stuart McLauchlan bought 1,500 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were purchased at an average price of A$24.04 per share, with a total value of A$36,054.00.

EBOS Group Stock Performance

The company has a debt-to-equity ratio of 81.88, a quick ratio of 0.76 and a current ratio of 1.24. The company has a market capitalization of $4.68 billion, a PE ratio of 18.62 and a beta of 0.18.

EBOS Group Announces Dividend

The firm also recently disclosed a Interim dividend, which will be paid on Thursday, March 26th. Investors of record on Thursday, March 26th will be issued a $0.427 dividend. The ex-dividend date is Wednesday, March 4th. This represents a dividend yield of 213.0%. EBOS Group’s payout ratio is 91.46%.

EBOS Group Company Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses.